These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38941485)

  • 21. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
    Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
    Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
    Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
    Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
    Fein KC; Gleeson JP; Newby AN; Whitehead KA
    Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of synergistic permeation enhancers for oral drug delivery.
    Whitehead K; Karr N; Mitragotri S
    J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation strategies to improve the efficacy of intestinal permeation enhancers
    Maher S; Brayden DJ
    Adv Drug Deliv Rev; 2021 Oct; 177():113925. PubMed ID: 34418495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
    Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
    IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
    Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
    Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
    Brayden DJ; Walsh E
    AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
    Falavigna M; Klitgaard M; Steene E; Flaten GE
    Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
    Makhlof A; Werle M; Tozuka Y; Takeuchi H
    J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.
    Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
    J Drug Target; 2005 Dec; 13(10):573-83. PubMed ID: 16390818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
    Brayden DJ; Stuettgen V
    Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing Oral Bioavailability of Domperidone Maleate: Formulation,
    Okur NÜ; Çağlar EŞ; Kaynak MS; Diril M; Özcan S; Karasulu HY
    Curr Drug Deliv; 2024; 21(7):1010-1023. PubMed ID: 36786136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
    Dening TJ; Douglas JT; Hageman MJ
    Mol Pharm; 2021 Aug; 18(8):3086-3098. PubMed ID: 34255531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing Intestinal Absorption of a Model Macromolecule via the Paracellular Pathway using E-Cadherin Peptides.
    Dening TJ; Siahaan TJ; Hageman MJ
    J Pharm Sci; 2021 May; 110(5):2139-2148. PubMed ID: 33359310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
    Patel N; Forbes B; Eskola S; Murray J
    Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.